chronic spontaneous urticaria
| 6 min read
A clinical trial showed that Rhapsido can safely and effectively treat chronic spontaneous urticaria; its developer Novartis hopes that’s just the start.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.
Learn the fundamental weighing principles and operational controls that support reliable sample preparation.
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
